Igene Biotechnology, Inc. (IGNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2009 | -140.74 Thousand USD | 96.47% |
| 2008 | -3.99 Million USD | -110.15% |
| 2007 | -1.89 Million USD | -64.31% |
| 2006 | -1.15 Million USD | 0.0% |
| 2003 | -2.19 Million USD | 31.06% |
| 2002 | -3.18 Million USD | 13.15% |
| 2001 | -3.67 Million USD | -62.86% |
| 2000 | -2.25 Million USD | 10.69% |
| 1999 | -2.52 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2010 Q1 | -549.04 Thousand USD | -42.1% |
| 2010 Q2 | -811.21 Thousand USD | -47.75% |
| 2010 Q3 | -627.23 Thousand USD | 22.68% |
| 2009 Q2 | -601.9 Thousand USD | -182.14% |
| 2009 FY | -140.74 Thousand USD | 96.47% |
| 2009 Q4 | -386.38 Thousand USD | -436.55% |
| 2009 Q1 | 732.73 Thousand USD | 153.62% |
| 2009 Q3 | 114.8 Thousand USD | 119.07% |
| 2008 Q1 | -870.23 Thousand USD | -106.53% |
| 2008 Q4 | -1.36 Million USD | -71.15% |
| 2008 Q3 | -798.46 Thousand USD | 16.45% |
| 2008 Q2 | -955.64 Thousand USD | -9.81% |
| 2008 FY | -3.99 Million USD | -110.15% |
| 2007 Q1 | -125.71 Thousand USD | 58.84% |
| 2007 Q2 | -415.72 Thousand USD | -230.69% |
| 2007 FY | -1.89 Million USD | -64.31% |
| 2007 Q4 | -421.35 Thousand USD | 27.92% |
| 2007 Q3 | -584.58 Thousand USD | -40.62% |
| 2006 FY | -1.15 Million USD | 0.0% |
| 2006 Q4 | -305.44 Thousand USD | -35.53% |
| 2006 Q3 | -225.37 Thousand USD | 55.29% |
| 2006 Q2 | -504.04 Thousand USD | -6.65% |
| 2006 Q1 | -472.6 Thousand USD | 0.0% |
| 2005 Q3 | -181.49 Thousand USD | 0.0% |
| 2004 Q1 | -920.08 Thousand USD | -36.37% |
| 2004 Q2 | -1.51 Million USD | -64.8% |
| 2004 Q3 | -1.08 Million USD | 28.13% |
| 2003 Q2 | -535.73 Thousand USD | -50.42% |
| 2003 FY | -2.19 Million USD | 31.06% |
| 2003 Q1 | -356.16 Thousand USD | 42.55% |
| 2003 Q3 | -632.1 Thousand USD | -17.99% |
| 2003 Q4 | -674.68 Thousand USD | -6.74% |
| 2002 Q2 | -787.41 Thousand USD | -9.94% |
| 2002 FY | -3.18 Million USD | 13.15% |
| 2002 Q1 | -716.23 Thousand USD | 58.3% |
| 2002 Q4 | -619.94 Thousand USD | 41.87% |
| 2002 Q3 | -1.06 Million USD | -35.43% |
| 2001 Q3 | -802.17 Thousand USD | -27.86% |
| 2001 Q2 | -627.37 Thousand USD | -19.33% |
| 2001 FY | -3.67 Million USD | -62.86% |
| 2001 Q1 | -525.76 Thousand USD | 10.98% |
| 2001 Q4 | -1.71 Million USD | -114.12% |
| 2000 Q3 | -652.18 Thousand USD | -16.01% |
| 2000 Q4 | -590.61 Thousand USD | 9.44% |
| 2000 Q2 | -562.16 Thousand USD | -24.83% |
| 2000 Q1 | -450.34 Thousand USD | 0.0% |
| 2000 FY | -2.25 Million USD | 10.69% |
| 1999 FY | -2.52 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Allied Energy Corporation | -314.46 Thousand USD | 55.242% |
| Earth Alive Clean Technologies Inc. | -4.47 Million USD | 96.855% |
| Lotus Bio-Technology Development Corp. | - USD | Infinity% |
| MagIndustries Corp. | -28.75 Million USD | 99.511% |
| Itafos Inc. | 3.86 Million USD | 103.645% |
| Potash America, Inc. | -332.76 Thousand USD | 57.704% |
| Yara International ASA | 48 Million USD | 100.293% |
| Yara International ASA | 48 Million USD | 100.293% |